Cepeginterferon ALFA-2B clinical trials
Also written Algeron.
How each study uses cepeginterferon ALFA-2B is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2013 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses cepeginterferon ALFA-2B is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected PatientsCompletedPhase 3BiocadNCT02103439Written as AlgeronHow we know
- An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis CCompletedPhase 3BiocadNCT01889433Written as AlgeronHow we know
- Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis CCompletedPhase 2/3BiocadNCT01740089Written as AlgeronHow we know
Codes
What other systems call cepeginterferon ALFA-2B · ClinicalTrials.gg INT015282
- UNII (FDA) 6J022WTC4YCEPEGINTERFERON ALFA-2BOne source FDA
- NCI Thesaurus C166944Cepeginterferon Alfa-2BOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 6J022WTC4Y | CEPEGINTERFERON ALFA-2B | One source FDA |
| NCI Thesaurus | C166944 | Cepeginterferon Alfa-2B | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.